1292 related articles for article (PubMed ID: 14685170)
1. Met, metastasis, motility and more.
Birchmeier C; Birchmeier W; Gherardi E; Vande Woude GF
Nat Rev Mol Cell Biol; 2003 Dec; 4(12):915-25. PubMed ID: 14685170
[No Abstract] [Full Text] [Related]
2. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase.
Maroun CR; Naujokas MA; Holgado-Madruga M; Wong AJ; Park M
Mol Cell Biol; 2000 Nov; 20(22):8513-25. PubMed ID: 11046147
[TBL] [Abstract][Full Text] [Related]
3. Targeting the hepatocyte growth factor/Met pathway in cancer.
De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
[TBL] [Abstract][Full Text] [Related]
4. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering.
Tulasne D; Paumelle R; Weidner KM; Vandenbunder B; Fafeur V
Mol Biol Cell; 1999 Mar; 10(3):551-65. PubMed ID: 10069803
[TBL] [Abstract][Full Text] [Related]
5. The MET receptor tyrosine kinase in invasion and metastasis.
Benvenuti S; Comoglio PM
J Cell Physiol; 2007 Nov; 213(2):316-25. PubMed ID: 17607709
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional basis of the serine protease-like hepatocyte growth factor beta-chain in Met binding and signaling.
Kirchhofer D; Yao X; Peek M; Eigenbrot C; Lipari MT; Billeci KL; Maun HR; Moran P; Santell L; Wiesmann C; Lazarus RA
J Biol Chem; 2004 Sep; 279(38):39915-24. PubMed ID: 15218027
[TBL] [Abstract][Full Text] [Related]
7. The multisubstrate adapter Gab1 regulates hepatocyte growth factor (scatter factor)-c-Met signaling for cell survival and DNA repair.
Fan S; Ma YX; Gao M; Yuan RQ; Meng Q; Goldberg ID; Rosen EM
Mol Cell Biol; 2001 Aug; 21(15):4968-84. PubMed ID: 11438654
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
[TBL] [Abstract][Full Text] [Related]
9. State of the structure address on MET receptor activation by HGF.
Linossi EM; Estevam GO; Oshima M; Fraser JS; Collisson EA; Jura N
Biochem Soc Trans; 2021 Apr; 49(2):645-661. PubMed ID: 33860789
[TBL] [Abstract][Full Text] [Related]
10. Phosphatase of regenerating liver sensitizes MET to functional activation by hepatocyte growth factor.
Kojima T; Funato Y; Miki H
Biochem J; 2019 May; 476(10):1419-1431. PubMed ID: 31036720
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of heparan sulfate and receptor binding domains of hepatocyte growth factor reveals that heparan sulfate-c-met interaction facilitates signaling.
Rubin JS; Day RM; Breckenridge D; Atabey N; Taylor WG; Stahl SJ; Wingfield PT; Kaufman JD; Schwall R; Bottaro DP
J Biol Chem; 2001 Aug; 276(35):32977-83. PubMed ID: 11435444
[TBL] [Abstract][Full Text] [Related]
12. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb2 Src homology 2 domain interactions.
Atabey N; Gao Y; Yao ZJ; Breckenridge D; Soon L; Soriano JV; Burke TR; Bottaro DP
J Biol Chem; 2001 Apr; 276(17):14308-14. PubMed ID: 11278639
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of MET receptor dimerization by the bacterial invasion protein InlB and the HGF/SF splice variant NK1.
Niemann HH
Biochim Biophys Acta; 2013 Oct; 1834(10):2195-204. PubMed ID: 23123275
[TBL] [Abstract][Full Text] [Related]
14. An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides.
Landgraf KE; Steffek M; Quan C; Tom J; Yu C; Santell L; Maun HR; Eigenbrot C; Lazarus RA
Nat Chem Biol; 2014 Jul; 10(7):567-73. PubMed ID: 24859116
[TBL] [Abstract][Full Text] [Related]
15. Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion.
Wang X; Le P; Liang C; Chan J; Kiewlich D; Miller T; Harris D; Sun L; Rice A; Vasile S; Blake RA; Howlett AR; Patel N; McMahon G; Lipson KE
Mol Cancer Ther; 2003 Nov; 2(11):1085-92. PubMed ID: 14617781
[TBL] [Abstract][Full Text] [Related]
16. Targeting the c-MET signaling pathway for cancer therapy.
Liu X; Yao W; Newton RC; Scherle PA
Expert Opin Investig Drugs; 2008 Jul; 17(7):997-1011. PubMed ID: 18549337
[TBL] [Abstract][Full Text] [Related]
17. Invasive growth: a genetic program.
Gentile A; Comoglio PM
Int J Dev Biol; 2004; 48(5-6):451-6. PubMed ID: 15349819
[TBL] [Abstract][Full Text] [Related]
18. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses.
Schaeper U; Gehring NH; Fuchs KP; Sachs M; Kempkes B; Birchmeier W
J Cell Biol; 2000 Jun; 149(7):1419-32. PubMed ID: 10871282
[TBL] [Abstract][Full Text] [Related]
19. Expression array analysis of the hepatocyte growth factor invasive program.
Cecchi F; Lih CJ; Lee YH; Walsh W; Rabe DC; Williams PM; Bottaro DP
Clin Exp Metastasis; 2015 Oct; 32(7):659-76. PubMed ID: 26231668
[TBL] [Abstract][Full Text] [Related]
20. The biological role of HGF-MET axis in tumor growth and development of metastasis.
Lesko E; Majka M
Front Biosci; 2008 Jan; 13():1271-80. PubMed ID: 17981628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
